Results 1,041-1,060 of 1,164 for speaker:Aidan Farrelly
- Public Accounts Committee: Financial Statements 2024: National Treatment Purchase Fund
Financial Statements 2023: Beaumont Hospital Board (9 Oct 2025) Aidan Farrelly: Does Ms Brady have a rough idea of the total amount that was misspent under the NTPF between the four hospitals, based on those reviews?
- Public Accounts Committee: Financial Statements 2024: National Treatment Purchase Fund
Financial Statements 2023: Beaumont Hospital Board (9 Oct 2025) Aidan Farrelly: How much has the NTPF recouped from misspent funds? I assume that if the officials do not have the first figure, they will not have the second figure, even for 2023.
- Public Accounts Committee: Financial Statements 2024: National Treatment Purchase Fund
Financial Statements 2023: Beaumont Hospital Board (9 Oct 2025) Aidan Farrelly: Does the NTPF intend to?
- Public Accounts Committee: Financial Statements 2024: National Treatment Purchase Fund
Financial Statements 2023: Beaumont Hospital Board (9 Oct 2025) Aidan Farrelly: That would strike me as interesting. If potentially funds have been spent and patients have had their services paid for twice, why would we not recoup that money?
- Public Accounts Committee: Financial Statements 2024: National Treatment Purchase Fund
Financial Statements 2023: Beaumont Hospital Board (9 Oct 2025) Aidan Farrelly: But they would have been treated otherwise. For Naas, for example, if I read the reporting right, the NTPF funding seems to have been spent during normal working hours, not outside them.
- Public Accounts Committee: Financial Statements 2024: National Treatment Purchase Fund
Financial Statements 2023: Beaumont Hospital Board (9 Oct 2025) Aidan Farrelly: They were potentially paid twice, if people are being paid to be there during normal working hours and then the service was being paid for under NTPF funding. My interpretation is that essentially they were being double-billed for something.
- Public Accounts Committee: Financial Statements 2024: National Treatment Purchase Fund
Financial Statements 2023: Beaumont Hospital Board (9 Oct 2025) Aidan Farrelly: Ms Brady just said it was not. That is my challenge. I am just trying to understand.
- Public Accounts Committee: Financial Statements 2024: National Treatment Purchase Fund
Financial Statements 2023: Beaumont Hospital Board (9 Oct 2025) Aidan Farrelly: I thank Ms Brady for her time. I also thank Ms Coyle for being here this morning. Could she outline how she and the board came to the realisation that something was wrong regarding the NTPF funding?
- Public Accounts Committee: Financial Statements 2024: National Treatment Purchase Fund
Financial Statements 2023: Beaumont Hospital Board (9 Oct 2025) Aidan Farrelly: The HSE then conducted an audit.
- Public Accounts Committee: Financial Statements 2024: National Treatment Purchase Fund
Financial Statements 2023: Beaumont Hospital Board (9 Oct 2025) Aidan Farrelly: Has that been published?
- Public Accounts Committee: Financial Statements 2024: National Treatment Purchase Fund
Financial Statements 2023: Beaumont Hospital Board (9 Oct 2025) Aidan Farrelly: Let us say for 2023, of the €11 million that the NTPF gave to Beaumont Hospital, are we saying that very strictly only €25,000 was misspent?
- Public Accounts Committee: Financial Statements 2024: National Treatment Purchase Fund
Financial Statements 2023: Beaumont Hospital Board (9 Oct 2025) Aidan Farrelly: Would Ms Coyle have any concerns that the issue could have been wider than just rheumatology?
- Public Accounts Committee: Financial Statements 2024: National Treatment Purchase Fund
Financial Statements 2023: Beaumont Hospital Board (9 Oct 2025) Aidan Farrelly: Was the HSE review just for 2019 or which years did it cover?
- Public Accounts Committee: Financial Statements 2024: National Treatment Purchase Fund
Financial Statements 2023: Beaumont Hospital Board (9 Oct 2025) Aidan Farrelly: The other eight departments will experience the same terms of reference timewise.
- Public Accounts Committee: Financial Statements 2024: National Treatment Purchase Fund
Financial Statements 2023: Beaumont Hospital Board (9 Oct 2025) Aidan Farrelly: So that is self-assessed. The hospital will do that, publish it and send it back.
- Public Accounts Committee: Financial Statements 2024: National Treatment Purchase Fund
Financial Statements 2023: Beaumont Hospital Board (9 Oct 2025) Aidan Farrelly: Were there recommendations from that HSE review other than broadening the scope of it?
- Public Accounts Committee: Financial Statements 2024: National Treatment Purchase Fund
Financial Statements 2023: Beaumont Hospital Board (9 Oct 2025) Aidan Farrelly: Was this review specific to Beaumont?
- Public Accounts Committee: Financial Statements 2024: National Treatment Purchase Fund
Financial Statements 2023: Beaumont Hospital Board (9 Oct 2025) Aidan Farrelly: What were the other recommendations?
- Public Accounts Committee: Financial Statements 2024: National Treatment Purchase Fund
Financial Statements 2023: Beaumont Hospital Board (9 Oct 2025) Aidan Farrelly: Do we foresee a possibility that we will be back here in six months or a year when the full review has been done and that €25,000 has multiplied considerably? Is there a flaw in the MOU or in the way it is communicated to professionals? Where potentially is this process falling down such that funds can be misspent?
- Public Accounts Committee: Financial Statements 2024: National Treatment Purchase Fund
Financial Statements 2023: Beaumont Hospital Board (9 Oct 2025) Aidan Farrelly: I noted from the 2023 accounts that there were concerns with regard to members of the board changing quite quickly. There was board changeover.